S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

NovaBay Pharmaceuticals, Inc.

NBY XASE
$1.50 +0.12 (+8.70%) ▲ 15-min delayed
Open
$1.40
High
$1.75
Low
$1.27
Volume
1.22M
Market Cap
$36.05M

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 4 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $0 $-22,141,000 $-3.80
FY 2025 $0 $-22,141,000 $-3.80
Q3 2025 $521.0K $-1,293,000 $-0.22
Q2 2025 $0 $-1,922,000 $-0.33

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026
Calendar →

Related Market News

No specific coverage for NBY yet. Check out our latest market news or earnings calendar.

Get NBY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NovaBay Pharmaceuticals, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.